Cargando…
Sulfonamides as Inhibitors of Leishmania – Potential New Treatments for Leishmaniasis
INTRODUCTION: Leishmaniasis is an endemic disease caused by the protozoan parasite Leishmania. Current treatments for the parasite are limited by cost, availability and drug resistance as the occurrence of leishmaniasis continues to be more prevalent. Sulfonamides are a class of compounds with medic...
Autores principales: | Katinas, Jade, Epplin, Rachel, Hamaker, Christopher, Jones, Marjorie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748876/ https://www.ncbi.nlm.nih.gov/pubmed/29399442 http://dx.doi.org/10.2174/2211352515666170216143401 |
Ejemplares similares
-
Draft Genome Sequences of Leishmania (Leishmania) amazonensis, Leishmania (Leishmania) mexicana, and Leishmania (Leishmania) aethiopica, Potential Etiological Agents of Diffuse Cutaneous Leishmaniasis
por: Batra, Dhwani, et al.
Publicado: (2019) -
Efficacy of Systemic Treatment for Leishmania tropica Cutaneous Leishmaniasis
por: SOLOMON, Michal, et al.
Publicado: (2022) -
Cutaneous Leishmaniasis Due to Leishmania aethiopica
por: van Henten, Saskia, et al.
Publicado: (2019) -
Leishmaniasis in Northern Morocco: Predominance of Leishmania infantum Compared to Leishmania tropica
por: Hakkour, Maryam, et al.
Publicado: (2019) -
Leishmania infection in blood donors: A new challenge in leishmaniasis transmission?
por: França, Adriana de Oliveira, et al.
Publicado: (2018)